Bowman (BWMN) Files Rule 144 Notice for 12,500-Share Sale via Merrill Lynch
Rhea-AI Filing Summary
Bowman Consulting Group Ltd. (BWMN) filed a Form 144 reporting a proposed sale of 12,500 shares of common stock through Merrill Lynch, Pierce, Fenner & Smith Incorporated on the Nasdaq, with an aggregate market value of $529,852.50. The filing lists the approximate date of sale as 09/24/2025 and shows 17,250,737 shares outstanding.
The securities to be sold were acquired on 05/13/2024 as stock compensation from Bowman Consulting Group Ltd., with 69,652 shares reported as acquired on that date and payment noted as cash. The filer reports no securities sold in the past three months and includes the required representation about material nonpublic information and trading-plan language.
Positive
- Shares were acquired as stock compensation on 05/13/2024, explicitly disclosed in the filing
- No securities sold in the past three months, as stated in the filing
- Proposed sale will be executed through a major broker (Merrill Lynch, Pierce, Fenner & Smith Incorporated)
Negative
- Proposed sale of 12,500 shares is disclosed, with an aggregate market value of $529,852.50
- Approximate sale date is 09/24/2025, indicating future dilution of insider-held shares to be realized on that date
Insights
TL;DR: Routine Rule 144 notice for a planned insider sale of shares acquired as compensation; no recent sales reported.
The filing documents a planned sale under Rule 144 of 12,500 common shares via a major broker with an indicated sale date of 09/24/2025. The shares were acquired as stock compensation on 05/13/2024. The disclosure that no securities were sold in the past three months suggests this is an initial report of a planned disposition rather than an ongoing selling pattern. From a market-impact perspective, the filing itself is procedural and informational.
TL;DR: Compliance-focused filing showing an insider complying with Rule 144 reporting requirements for a planned sale.
The notice includes the standard attestation that the person does not possess undisclosed material adverse information and references trading-plan language, indicating attention to regulatory compliance. The shares were acquired as stock compensation, which is relevant to governance disclosure. No prior three-month sales are reported, and the transaction will be executed through an established broker, Merrill Lynch.